Vertex Form 144: Insider sales reported

Vertex Pharmaceuticals reported Form 144 sales by a reporting person.

Rhea-AI Filing Summary

Vertex Pharmaceuticals reported Form 144 sales by a reporting person. The excerpt lists sales by E Morrey Atkinson of 1,751 common shares on 02/11/2026 for $806,212.93, 2,031 common shares on 02/17/2026 for $994,093.26, and 817 common shares on 02/18/2026 for $386,996.56. The filing also shows 668 common shares tied to a restricted stock vesting on 02/24/2026.

Insights

Securities Compliance Specialist

Form 144 lists specific sale transactions and a restricted stock vesting event.

The excerpt records three reported dispositions by E Morrey Atkinson on 02/11/2026, 02/17/2026, and 02/18/2026 with the exact share counts and dollar amounts shown in the table.

Timing and proceeds are explicit for each row; cash‑flow treatment and whether sales were brokered or private are not detailed in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What sales does the VRTX Form 144 report show?

The filing shows three reported sales by E Morrey Atkinson: 1,751 shares on 02/11/2026 for $806,212.93, 2,031 shares on 02/17/2026 for $994,093.26, and 817 shares on 02/18/2026 for $386,996.56.

Does the excerpt show any restricted stock activity for VRTX?

Yes. The excerpt lists 668 common shares tied to a restricted stock vesting event dated 02/24/2026, identified as compensation and attributed to the issuer in the table.

Who is the reporting person named on the VRTX excerpt?

The reporting person listed for the three sale rows is E Morrey Atkinson with an address at 50 Northern Avenue, Boston, MA 02210, shown alongside each transaction date, share count, and dollar amount.

Does the provided excerpt state how the sales were executed?

The excerpt includes transaction dates, share counts, and dollar amounts but does not specify execution method; brokerage or privately negotiated sale details are not listed in the provided rows.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 10:35 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001914164
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	Atkinson Edward Morrow III
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	668	324881.80	254034190	02/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/24/2026	Restricted Stock Vesting	Issuer			668	02/24/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
E Morrey Atkinson 50 Northern Avenue Boston MA 02210	Common	02/11/2026	1751	806212.93
E Morrey Atkinson 50 Northern Avenue Boston MA 02210	Common	02/17/2026	2031	994093.26
E Morrey Atkinson 50 Northern Avenue Boston MA 02210	Common	02/18/2026	817	386996.56

144: Remarks and Signature

Remarks
Date of Notice	02/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Audrey McMillen, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for E Morrey Atkinson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)